Management Team
The company has a seasoned and successful management team that has created powerful development partners. In the inner circle are three executives that have taken companies from founding to public offering or major merger and acquisition exits.
Paul Bhola Chairman, Chief Executive Officer, Chairman of the Board of Directors and Founder
Paul is the founder and conceptual genesis of Symbiotic Systems. Paul is an entrepreneur with a passion for innovation in the areas of technology, life science, and clean energy. Paul has over twenty years industry experience in large-scale agricultural, distributed infrastructure and commercial developments. His research into photonics and photochemistry resulted in the company’s patented technology.
Paul’s background in finance, marketing, design, and project management provides considerable industry specific knowledge and includes the development of over one hundred fifty million dollars in project financing for commercial, residential, and bio-fuels contracts. Paul attended Humboldt State University with an emphasis on international politics and business. His management experience includes over two decades of team management and leadership growth development.
Adam Blejski, Chief Operating Officer
Adam is a sales and operations expert with 25+ years’ experience and specializes in high-growth startups focused on healthcare technology and innovation. Adam co-founded Parallel 6, Inc. in 2010 and held roles of VP Digital Services, VP Sales and Marketing and VP Sales Operations. Parallel 6 developed the Captive Reach mobile platform for the commercial sector as well as GovReach for the government sector and Clinical Reach for use in clinical trials to facilitate decentralized clinical trial operations. Parallel 6, Inc. was acquired by PRA Health Sciences in 2017 and was absorbed as part of PRA’s technology stack. Adam was responsible for several work streams related to the integration of the business unit post acquisition and business development bringing the platform to market for PRA. He assumed the global role of Director of Technical Production for the Mobile Health Platform business unit at PRA in 2018. PRA was then acquired by ICON, PLC. in 2021.
Prior to Parallel 6, and PRA/ICON, Adam held sales and operations roles for companies such as Uline, Arrow Electronics, Sodexo, The Field Museum and Dawn Foods. He leverages his background in building teams and processes in high growth scenarios and technology innovation to lead Symbiotic Systems on all aspects of the operation.
Kenneth Happel, Chief Technology Officer
Mr. Happel has been founding, building, and leading high-tech organizations for nearly 50 years. He became a pioneer and an expert in artificial intelligence (AI) more than a decade before the term was coined. He is an expert in the use of advanced mathematics to create knowledge discovery systems.
In 1974 Mr. Happel founded an artificial intelligence (AI) based computer integrated materials design and manufacturing (CIM) company that compounded engineering plastics based on starches instead of oil and was taken public by its mezzanine funders on the UK stock exchange. In 1985 he founded a second company focusing on autonomous intelligent design and manufacturing systems for hypersonic aircraft, advanced materials manufacturing, multisource intelligence-data fusion, image analysis, image exploitation, distributed C4I and autonomous logistics planning. It was acquired by General Dynamics, Inc. in 1989. In 1992 he founded a revolutionary intelligent network company for secure financial transaction processing that was caught in the Dot-Com crash weeks before its planned $650 million dollar IPO in the USA. In 2015, Mr. Happel founded of Ontologica LLC, the licensor of Triad™ knowledge discovery and hyperspectral sensor technology.
In 2023 Mr. Happel joined Symbiotic Systems as its CTO and is co-inventor of Symbiotic Systems’ U.S. provisional patent application 63/554,948: Apparatus And Methods For Narrow Bandwidth Control Of Plant Metabolic Processes, filed, 02/16/2024.